Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients
Sponsor: Amira Mohamed Zidan
Summary
This study aims to determine the prevalence of antiviral drug resistance among Egyptian patients with chronic hepatitis B virus (HBV) infection and to identify the associated demographic, clinical, and virological risk factors. Understanding patterns of resistance will help improve treatment selection and optimize long-term management strategies for HBV patients.
Official title: Prevalence and Risk Factors Associated With Resistance to Antiviral Therapy in Egyptian Patients With Chronic Hepatitis B Virus Infection
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2025-12-01
Completion Date
2026-12-01
Last Updated
2025-12-10
Healthy Volunteers
No